Search - tctmd.com

Displaying 241 - 259 of 259

Sort: Relevancy | Date

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

L.A. McKeown

April 23, 2019

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

News Industry News

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

August 27, 2018

News Daily News

Low BP Tied to Poor Outcomes in Hospitalized Patients With HFpEF

Todd Neale

February 20, 2018

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

Presentation Controversies and Advances 2017

HFPEF – Echo with Strain vs. MRI T1 Mapping

Presenter: Eric Schelbert

November 17, 2017

News Conference News AHA 2016

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

Shelley Wood

November 16, 2016

Presentation TCT 2016

Interatrial Shunts in HFpEF: Focus on Corvia

Presenter: Josep Rodés-Cabau, Nir Uriel, Sanjiv Shah

November 01, 2016

Presentation TCT 2016

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFpEF

Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Peter Carson

October 31, 2016

News Industry News

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

May 12, 2016

News Industry News

Mast Therapeutics Announces Positive Top-Line Results From Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Conducted At Mayo Clinic

January 31, 2016

Presentation TCT 2013

HFpEF State-of-the-Art: Where do we stand?

Presenter: Peter Carson

October 28, 2013

Presentation TCT 2012

HFPEF: Overview of Pathophysiology and Therapies

Presenter: William Little

October 23, 2012

Presentation TCT 2012

DC Devices: Interatrial Shunt for HFPEF

Presenter: Ted Feldman

October 23, 2012

Presentation TCT 2012

Transcatheter Interatrial Shunt for Heart Failure with Preserved Ejection Fraction (HFPEF)

Presenter: Brad Munt

October 22, 2012

CME

The Role of Atrial Shunts in the Treatment of HFpEF

CME

Advertisement

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

Low BP Tied to Poor Outcomes in Hospitalized Patients With HFpEF

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

HFPEF – Echo with Strain vs. MRI T1 Mapping

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

Interatrial Shunts in HFpEF: Focus on Corvia

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFpEF

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

Mast Therapeutics Announces Positive Top-Line Results From Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Conducted At Mayo Clinic

HFpEF State-of-the-Art: Where do we stand?

HFPEF: Overview of Pathophysiology and Therapies

DC Devices: Interatrial Shunt for HFPEF

Transcatheter Interatrial Shunt for Heart Failure with Preserved Ejection Fraction (HFPEF)

The Role of Atrial Shunts in the Treatment of HFpEF

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content